Skip to main content

Ally Bridge Group (NY) LLC

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1822947 NEW YORK, NY

Position in PRAX

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$10,571,053
+$4,711,033 QoQ
Shares Held
32,810
+65.0% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
10.50%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PRAX Over Time

Shares Held

Position Value (USD)

Derivatives in PRAX

reported options exposure · as of Sep 30, 2025
CallValue
$5,300,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Ally Bridge Group (NY) LLC holds $91,014,294 across 19 Biotechnology names. PRAX ranks #1 (11.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRAX
Praxis Precision Medicines, Inc.
This page
32,810 $10,571,053

All Filings in PRAX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,571,053 32,810
2025-12-31 $5,860,020 19,882
2025-09-30 $5,300,000 100,000
2025-06-30 $3,401,004 80,880
2025-03-31 $3,619,690 95,582
2024-12-31 $3,461,814 44,982
2024-09-30 $4,211,064 73,185
2024-06-30 $6,343,755 153,379
2024-03-31 $9,731,835 159,486
2023-12-31 $1,569,046 70,424